Jeanne Volatron, Co-Founder and CEO of EVerZom Nicolas Rousseau

EVerZom Secures €10M to Advance Groundbreaking Exosome-Based Biotherapies for Inflammatory Diseases

EVerZom, a pioneering biotechnology firm based in France, has secured €10 million in a Series A funding round to propel the clinical development of its first therapeutic candidate and further scale its exosome biomanufacturing platform. The investment, which brings together major players like Capital Grand Est, the European Innovation Council (EIC) Fund, Sorbonne Venture by…

Read More

VentureSouth Fuels Southeastern Innovation with $5.5 Million in Early-Stage Investments

VentureSouth, recognized as one of North America’s top 10 angel groups, has announced a dynamic start to 2024 with investments totaling $5.5 million into 24 early-stage companies across the Southeast. The group also distributed nearly $2 million in returns to investors from previous successful investments, showcasing its commitment to fostering regional innovation and economic growth….

Read More

SurrealDB Redefines Database Tech with $20 Million Boost and Surreal Cloud Launch

In a significant leap forward for database innovation, SurrealDB has secured a substantial $20 million investment led by FirstMark and Georgian, with additional support from Crew Capital and Alumni Ventures. This latest funding round, building upon their initial $6 million seed investment, marks a pivotal moment for SurrealDB as it continues to disrupt the database…

Read More
Michael Berthold CEO KINME

KNIME Secures €27.5M in Funding to Enhance AI and Data Science Solutions

Zurich-based KNIME, a leader in open-source data science and AI, has announced a significant funding milestone. On August 6, the company revealed that it has raised $30 million (approximately €27.5 million) from its long-term investor Invus. This investment boosts Invus’s total commitment to KNIME to around $50 million (approximately €45.7 million). This latest injection of…

Read More

Unrivaled Excellence: Cognigy Secures Consecutive Win in AI Breakthrough Awards 2024

Cognigy, a pioneer in AI-driven customer service solutions, proudly announces its consecutive victory in the prestigious AI Breakthrough Awards 2024, clinching the title of “Best Natural Language Understanding Solution” for the second year running. Hosted by AI Breakthrough, a leading market intelligence firm, the annual awards program recognizes outstanding achievements in artificial intelligence across various…

Read More

Signol Secures £2.5M Investment to Revolutionize Sustainability in Aviation and Shipping

Signol, a pioneering sustainability startup harnessing behavioral science to cut emissions in aviation and shipping, has announced a successful £2.5 million funding round. This investment highlights the growing recognition of human-centered solutions in addressing climate change within challenging industries. The investment round was led by TMV, a New York-based venture capital firm renowned for its…

Read More

Tembo Secures $14M Funding to Expand Postgres Ecosystem Capabilities

Tembo, a leading provider of managed services for Postgres, has announced the successful closure of a $14 million Series A funding round, led by GreatPoint Ventures. Other participants include Venrock, Grand Ventures, Wireframe Ventures, Defined Capital, Cintrifuse Capital, and notable angel investors. This funding will bolster Tembo’s mission to revolutionize data management by leveraging Postgres,…

Read More

Linker Finance Secures $3.7 Million Seed Round to Revolutionize Digital Banking for Community Banks

Linker Finance, an innovative platform designed to enhance digital banking experiences for community banks, has successfully closed a $3.7 million seed funding round. The investment round was led by Ten One Ten Ventures and Chingona Ventures, with additional support from Audaz Capital, Techstars, Commerce Ventures, Bank of Brodhead, and Angeles Investors. Angel investors including Edrizio…

Read More

Pinetree Therapeutics Raises $17M to Propel Breakthrough Cancer Therapies with Innovative Protein Degradation Platform

Pinetree Therapeutics, Inc., a trailblazer in targeted protein degradation (TPD) technology, has successfully closed a Series A funding round, raising $17 million to advance its AbReptor™ platform. This investment round was co-led by STIC Investments and DSC Investment, with new participation from Atinum Investment, Quantum FA, and S&S Investment, alongside existing backers DSC Investment, Schmidt,…

Read More